miR-92a作为潜在的生物标志物和心力衰竭的治疗点:来自人类和小鼠研究的证据
Luya Zhu1, Yuqing Li2, Wenqi Pan3
1Department of Cardiovascular Medicine, Fuyang Hospital of Traditional Chinese Medicine, Fuyang, 311400, China.
Journal of cardiothoracic surgery
|January 24, 2026
概括
微RNA-92a (miR-92a) 在慢性心力衰竭 (CHF) 中升高. 抑制miR-92a可以改善心脏功能和重塑,这表明它有可能成为心力衰竭生物标志物.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 慢性心力衰竭 (CHF) 是一种复杂的疾病,具有显著的发病率.
- 微RNAs (miRNAs) 在心血管调节中起着至关重要的作用.
- 微RNA-92a (miR-92a) 在CHF病变发生中的特定作用需要进一步阐明.
研究的目的:
- 为了研究心血管疾病患者的miR-92a表达水平.
- 使用小鼠模型探索miR-92a在心脏重塑中的机械作用.
- 评估调节心力衰竭中miR-92a的治疗潜力.
主要方法:
- 量化逆转录聚合酶连锁反应 (qRT-PCR) 用于测量30名心血管疾病患者和30名对照者的血miR-92a水平.
- 一个横向大动脉收缩 (TAC) 鼠标模型被用来诱导心力衰竭.
- 在TAC小鼠中进行了由腺相关病毒 (AAV) 介导的miR-92a抑制或过度表达,通过心声扫描 (EF,FS,LVIDd,LVIDs) 评估心脏功能.
主要成果:
- 与健康对照组相比,CHF患者的血miR-92a水平显著升高 (p < 0.01).
- 在小鼠中,TAC诱导的心力衰竭也显示心脏miR-92a表达的增加 (p < 0.01).
- 在TAC小鼠模型中抑制miR-92a导致心脏功能显著改善,包括增加射出分数 (EF) 和分数缩短 (FS),以及减少左心室内径 (LVIDd,LVIDs) (p <0.05).
结论:
- 在慢性心力衰竭中,miR-92a被上调.
- 调节miR-92a表达影响心脏重塑和功能.
- miR-92a作为心力衰竭的新型诊断和治疗生物标志物具有前景.
相关概念视频
The Evidence for Evolution
47.7K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.7K
Heart Failure II: Pathophysiology
812
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
812
Pathophysiology of Heart Failure
3.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
Heart Failure I: Introduction
751
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
751
Heart Failure VI: Adjunct Therapies
289
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
289
Heart Failure Drugs: Diuretics
846
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
846


